Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Wakefield

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Journal of the American College of Surgeons|November 16, 2001
Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous systemV Sullivan, P M Denk, S S Sonnad, et al.
Cardiovascular Surgery (London, England)|June 3, 1999
Developments in diagnosis and classification of venous disorders: non-invasive diagnosisT G Lynch, M C Dalsing, K Ouriel, et al.
Acta Chirurgica Scandinavica|November 1, 1986
Endothelial cell seeding efficiency onto expanded polytetrafluorethylene grafts with different coatingsB Lindblad, W E Burkel, T W Wakefield, et al.
Cardiovascular Surgery (London, England)|August 1, 1997
Research and clinical issues in chronic venous diseaseJ J Ricotta, M C Dalsing, K Ouriel, et al.
ASAIO Transactions|July 1, 1989
A novel approach to anticoagulation controlJ S Kim, C Vincent, C L Teng, et al.
Surgery|July 1, 1986
Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine modelT W Wakefield, B Lindblad, W M Whitehouse, et al.
Experientia|March 15, 1988
Lack of effect of dihydroergotamine on endothelial and smooth muscle cell proliferation and endothelial cell prostanoid productionB Lindblad, W E Burkel, T W Wakefield, et al.
Journal of Vascular Surgery|June 1, 1989
Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulationT W Wakefield, I Ucros, T F Kresowik, et al.
Journal of the National Medical Association|November 1, 1992
Time-related effects of heparin sulfate on regional and systemic anticoagulationC K Vincent, T W Wakefield, B Lindblad, et al.
AAPS Pharmsci|December 14, 2001
Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine modelL M Lee, L C Chang, S Wrobleski, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Journal of the American College of Surgeons|November 16, 2001
Ligation versus anticoagulation: treatment of above-knee superficial thrombophlebitis not involving the deep venous systemV Sullivan, P M Denk, S S Sonnad, et al.
Cardiovascular Surgery (London, England)|June 3, 1999
Developments in diagnosis and classification of venous disorders: non-invasive diagnosisT G Lynch, M C Dalsing, K Ouriel, et al.
Acta Chirurgica Scandinavica|November 1, 1986
Endothelial cell seeding efficiency onto expanded polytetrafluorethylene grafts with different coatingsB Lindblad, W E Burkel, T W Wakefield, et al.
Cardiovascular Surgery (London, England)|August 1, 1997
Research and clinical issues in chronic venous diseaseJ J Ricotta, M C Dalsing, K Ouriel, et al.
ASAIO Transactions|July 1, 1989
A novel approach to anticoagulation controlJ S Kim, C Vincent, C L Teng, et al.
Surgery|July 1, 1986
Attenuation of hemodynamic and hematologic effects of heparin-protamine sulfate interaction after aortic reconstruction in a canine modelT W Wakefield, B Lindblad, W M Whitehouse, et al.
Experientia|March 15, 1988
Lack of effect of dihydroergotamine on endothelial and smooth muscle cell proliferation and endothelial cell prostanoid productionB Lindblad, W E Burkel, T W Wakefield, et al.
Journal of Vascular Surgery|June 1, 1989
Decreased oxygen consumption as a toxic manifestation of protamine sulfate reversal of heparin anticoagulationT W Wakefield, I Ucros, T F Kresowik, et al.
Journal of the National Medical Association|November 1, 1992
Time-related effects of heparin sulfate on regional and systemic anticoagulationC K Vincent, T W Wakefield, B Lindblad, et al.
AAPS Pharmsci|December 14, 2001
Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine modelL M Lee, L C Chang, S Wrobleski, et al.
Pageof 12